• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例因特发性肺动脉高压长期静脉输注依前列醇治疗导致巨大甲状腺肿合并气道狭窄的病例。

A Case of Giant Goiter Associated with Airway Stenosis Caused by Long-Term Intravenous Epoprostenol Therapy for Idiopathic Pulmonary Arterial Hypertension.

作者信息

Nishiura Kazuto, Nakazato Kazuhiko, Yokokawa Tetsuro, Suzuki Yoshinori, Kurosawa Yuta, Wada Kento, Shimizu Takeshi, Oikawa Masayoshi, Kobayashi Atsushi, Sugimoto Koichi, Shakespear Norshalena, Hashimoto Yuko, Takeishi Yasuchika

机构信息

Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima 960-1295, Japan.

Department of Diagnostic Pathology, Fukushima Medical University, Fukushima 960-1295, Japan.

出版信息

J Clin Med. 2023 Oct 4;12(19):6359. doi: 10.3390/jcm12196359.

DOI:10.3390/jcm12196359
PMID:37835003
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10573889/
Abstract

Idiopathic pulmonary arterial hypertension is a progressive and life-threatening disease with pulmonary vasculature remodeling, leading to right-sided heart failure. Epoprostenol (prostaglandin I) is highly recommended for patients with severe pulmonary arterial hypertension (PAH) categorized by the World Health Organization as functional class III or IV. It has been reported that prostaglandin I analogs can cause thyroid gland swelling and abnormal thyroid function. A 34-year-old woman was diagnosed with idiopathic pulmonary arterial hypertension and started receiving continuous intravenous epoprostenol. Three years after starting epoprostenol, she began complaining of neck swelling and was diagnosed with Graves' disease. The patient's thyroid function was controlled by thiamazole and levothyroxine; nevertheless, her thyroid gland enlargement worsened as the epoprostenol dose was titrated. After 20 years, she developed respiratory failure with a giant goiter leading to airway stenosis, and she passed away. The pathological autopsy confirmed a massive goiter associated with hyperthyroidism and airway stenosis. We experienced a case of idiopathic pulmonary hypertension with a giant goiter and airway stenosis after long-term intravenous epoprostenol therapy.

摘要

特发性肺动脉高压是一种进行性且危及生命的疾病,伴有肺血管重塑,可导致右心衰竭。依前列醇(前列腺素I)强烈推荐用于世界卫生组织分类为功能Ⅲ级或Ⅳ级的重度肺动脉高压(PAH)患者。据报道,前列腺素I类似物可导致甲状腺肿大和甲状腺功能异常。一名34岁女性被诊断为特发性肺动脉高压,并开始接受依前列醇持续静脉输注治疗。开始使用依前列醇三年后,她开始抱怨颈部肿胀,并被诊断为格雷夫斯病。患者的甲状腺功能通过甲巯咪唑和左甲状腺素控制;然而,随着依前列醇剂量的滴定,她的甲状腺肿大加剧。20年后,她因巨大甲状腺肿导致气道狭窄而出现呼吸衰竭,并去世。病理尸检证实存在与甲状腺功能亢进和气道狭窄相关的巨大甲状腺肿。我们遇到了一例长期静脉输注依前列醇治疗后出现巨大甲状腺肿和气道狭窄的特发性肺动脉高压病例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e2/10573889/13cac847587d/jcm-12-06359-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e2/10573889/404d6e174558/jcm-12-06359-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e2/10573889/97f73002479b/jcm-12-06359-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e2/10573889/65264085d8eb/jcm-12-06359-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e2/10573889/a699b15bde82/jcm-12-06359-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e2/10573889/13cac847587d/jcm-12-06359-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e2/10573889/404d6e174558/jcm-12-06359-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e2/10573889/97f73002479b/jcm-12-06359-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e2/10573889/65264085d8eb/jcm-12-06359-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e2/10573889/a699b15bde82/jcm-12-06359-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e2/10573889/13cac847587d/jcm-12-06359-g005.jpg

相似文献

1
A Case of Giant Goiter Associated with Airway Stenosis Caused by Long-Term Intravenous Epoprostenol Therapy for Idiopathic Pulmonary Arterial Hypertension.一例因特发性肺动脉高压长期静脉输注依前列醇治疗导致巨大甲状腺肿合并气道狭窄的病例。
J Clin Med. 2023 Oct 4;12(19):6359. doi: 10.3390/jcm12196359.
2
Thyroid Dysfunction in Patients with Pulmonary Artery Hypertension (PAH): The Effect of Therapies Affecting the Prostanoid Pathway.肺动脉高压(PAH)患者的甲状腺功能障碍:影响前列环素途径的治疗的影响。
Lung. 2019 Dec;197(6):761-768. doi: 10.1007/s00408-019-00283-8. Epub 2019 Nov 6.
3
Silicone stent placement for tracheal stenosis induced by a giant goiter due to Graves' disease: a case report.硅酮支架置入治疗格雷夫斯病所致巨大甲状腺肿引起的气管狭窄:一例报告
Gland Surg. 2024 Apr 29;13(4):578-583. doi: 10.21037/gs-23-499. Epub 2024 Apr 17.
4
Pancreatic enlargement in a patient receiving therapy with vasodilators for pulmonary arterial hypertension: a case report.一名接受血管扩张剂治疗肺动脉高压的患者出现胰腺肿大:病例报告
Abdom Radiol (NY). 2022 Jun;47(6):1948-1953. doi: 10.1007/s00261-022-03458-9. Epub 2022 Mar 7.
5
Epoprostenol Therapy for Pulmonary Arterial Hypertension.依前列醇治疗肺动脉高压
Acta Med Okayama. 2015;69(3):129-36. doi: 10.18926/AMO/53519.
6
Effect of epoprostenol on the thyroid gland: enlargement and secretion of thyroid hormone.依前列醇对甲状腺的影响:甲状腺肿大及甲状腺激素分泌
Endocr Pract. 2009 Mar;15(2):116-21. doi: 10.4158/EP.15.2.116.
7
Graves' disease presenting as bi-ventricular heart failure with severe pulmonary hypertension and pre-eclampsia in pregnancy--a case report and review of the literature.以双心室心力衰竭、重度肺动脉高压和妊娠期先兆子痫为表现的格雷夫斯病——病例报告及文献复习
BMC Res Notes. 2014 Nov 18;7:814. doi: 10.1186/1756-0500-7-814.
8
Successful transition from intravenous epoprostenol to oral selexipag and inhaled iloprost in a case of severe pulmonary arterial hypertension associated with systemic lupus erythematosus.成功将静脉内依前列醇转换为口服塞来昔帕格和吸入伊洛前列素治疗系统性红斑狼疮相关严重肺动脉高压的病例。
Mod Rheumatol Case Rep. 2022 Jun 24;6(2):183-188. doi: 10.1093/mrcr/rxac009.
9
Initial and programmed combination therapy with oral drugs for severe idiopathic pulmonary arterial hypertension.口服药物用于重度特发性肺动脉高压的初始及序贯联合治疗
Int Heart J. 2011;52(5):323-6. doi: 10.1536/ihj.52.323.
10
Rapid and high-dose titration of epoprostenol improves pulmonary hemodynamics and clinical outcomes in patients with idiopathic and heritable pulmonary arterial hypertension.依前列醇的快速大剂量滴定可改善特发性和遗传性肺动脉高压患者的肺血流动力学及临床结局。
J Cardiol. 2016 Dec;68(6):542-547. doi: 10.1016/j.jjcc.2015.11.012. Epub 2016 Apr 20.

引用本文的文献

1
Thyroid dysfunction and pulmonary arterial hypertension: A bidirectional mendelian randomization study.甲状腺功能障碍与肺动脉高压:一项双向孟德尔随机化研究。
Int J Cardiol Heart Vasc. 2025 Jul 10;60:101747. doi: 10.1016/j.ijcha.2025.101747. eCollection 2025 Oct.

本文引用的文献

1
A new treatment strategy for airway obstruction induced by a giant benign goiter: A case report.巨大良性甲状腺肿致气道梗阻的一种新治疗策略:病例报告
Exp Ther Med. 2023 Jun 23;26(2):376. doi: 10.3892/etm.2023.12075. eCollection 2023 Aug.
2
Tolerability, safety and survival in patients with severe pulmonary arterial hypertension treated with intravenous epoprostenol (Veletri): a prospective, 6-months, open label, observational, non-interventional study.静脉注射依前列醇(Veletri)治疗重度肺动脉高压患者的耐受性、安全性和生存情况:一项前瞻性、6 个月、开放标签、观察性、非干预性研究。
Respir Res. 2023 Jan 18;24(1):18. doi: 10.1186/s12931-022-02296-z.
3
Comprehensive immunophenotypic analysis reveals the pathological involvement of Th17 cells in Graves' disease.
全面免疫表型分析揭示了 Th17 细胞在格雷夫斯病中的病理作用。
Sci Rep. 2022 Oct 7;12(1):16880. doi: 10.1038/s41598-022-19556-z.
4
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南。
Eur Heart J. 2022 Oct 11;43(38):3618-3731. doi: 10.1093/eurheartj/ehac237.
5
Perioperative management of patients with pulmonary hypertension undergoing non-cardiothoracic, non-obstetric surgery: a systematic review and expert consensus statement.肺高血压患者非心胸、非产科手术的围手术期管理:系统评价和专家共识声明。
Br J Anaesth. 2021 Apr;126(4):774-790. doi: 10.1016/j.bja.2021.01.005. Epub 2021 Feb 19.
6
Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol.接受依前列醇治疗的肺动脉高压患者出现甲状腺肿
Case Rep Pulmonol. 2020 Jan 23;2020:1617253. doi: 10.1155/2020/1617253. eCollection 2020.
7
Risk stratification and medical therapy of pulmonary arterial hypertension.肺动脉高压的风险分层与药物治疗。
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.01889-2018. Print 2019 Jan.
8
Effect of treatment with epoprostenol and endothelin receptor antagonists on the development of thyrotoxicosis in patients with pulmonary arterial hypertension.依前列醇和内皮素受体拮抗剂治疗对肺动脉高压患者甲状腺毒症发生发展的影响。
Endocr J. 2017 Dec 28;64(12):1173-1180. doi: 10.1507/endocrj.EJ17-0155. Epub 2017 Sep 9.
9
Effectiveness and Outcome of Pulmonary Arterial Hypertension-Specific Therapy in Japanese Patients With Pulmonary Arterial Hypertension.肺动脉高压特异性治疗在日本肺动脉高压患者中的疗效和结局。
Circ J. 2017 Dec 25;82(1):275-282. doi: 10.1253/circj.CJ-17-0139. Epub 2017 Jul 26.
10
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis.2016年美国甲状腺协会甲状腺功能亢进症及其他甲状腺毒症病因的诊断和管理指南。
Thyroid. 2016 Oct;26(10):1343-1421. doi: 10.1089/thy.2016.0229.